Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease
Although only a small fraction will ever develop the active form of tuberculosis (ATB) disease, chemoprophylaxis treatment in latent TB infected (LTBI) individuals is an effective strategy to control pathogen transmission. Characterizing immune responses in LTBI upon chemoprophylactic treatment is i...
Principais autores: | Burel, JG, Singhania, A, Dubelko, P, Muller, J, Tanner, R, Parizotto, E, Dedicoat, M, Fletcher, TE, Dunbar, J, Cunningham, AF, Lindestam Arlehamn, CS, Catanzaro, DG, Catanzaro, A, Rodwell, T, McShane, H, O'Shea, MK, Peters, B |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Elsevier
2021
|
Registros relacionados
-
Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants
por: O'Shea, M, et al.
Publicado em: (2014) -
Immunological correlates of mycobacterial growth inhibition describe a spectrum of tuberculosis infection
por: O'Shea, M, et al.
Publicado em: (2018) -
In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy
por: Mcshane, H, et al.
Publicado em: (2017) -
Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review.
por: Elisea Avalos, et al.
Publicado em: (2015-01-01) -
Distinct transcriptional and anti-mycobacterial profiles of peripheral blood monocytes dependent on the ratio of monocytes: lymphocytes
por: Naranbhai, V, et al.
Publicado em: (2015)